Depot haloperidol treatment in outpatients with schizophrenia on monotherapy: impact of CYP2D6 polymorphism on pharmacokinetics and treatment outcome (Q80714802)
Jump to navigation
Jump to search
scientific article published on 01 August 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Depot haloperidol treatment in outpatients with schizophrenia on monotherapy: impact of CYP2D6 polymorphism on pharmacokinetics and treatment outcome |
scientific article published on 01 August 2007 |
Statements
Depot haloperidol treatment in outpatients with schizophrenia on monotherapy: impact of CYP2D6 polymorphism on pharmacokinetics and treatment outcome (English)
Georgios Panagiotidis
Holger W Arthur
Marja-Liisa Dahl
Folke Sjöqvist